Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Tyra Biosciences Inc (TYRA)

Tyra Biosciences Inc (TYRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.55 -0.37 (-4.67%) 04/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.92 +0.37 (+4.90%) 18:37 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.07
Day High
7.67
Open 7.67
Previous Close 7.92 7.92
Volume 418,200 418,200
Avg Vol 394,080 394,080
Stochastic %K 19.11% 19.11%
Weighted Alpha -62.36 -62.36
5-Day Change -0.75 (-9.04%) -0.75 (-9.04%)
52-Week Range 6.42 - 29.60 6.42 - 29.60
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 420,473
  • Shares Outstanding, K 53,090
  • Annual Sales, $ 0 K
  • Annual Income, $ -86,480 K
  • EBIT $ -104 M
  • EBITDA $ -104 M
  • 60-Month Beta 1.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.04

Options Overview Details

View History
  • Implied Volatility 203.06% ( +37.21%)
  • Historical Volatility 67.86%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 203.06% on 04/09/25
  • IV Low 35.79% on 05/14/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 347
  • Open Int (30-Day) 336

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.49
  • Number of Estimates 5
  • High Estimate -0.41
  • Low Estimate -0.56
  • Prior Year -0.35
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.42 +17.60%
on 04/09/25
Period Open: 10.16
11.82 -36.13%
on 03/14/25
-2.61 (-25.69%)
since 03/10/25
3-Month
6.42 +17.60%
on 04/09/25
Period Open: 15.20
17.27 -56.28%
on 01/15/25
-7.65 (-50.33%)
since 01/10/25
52-Week
6.42 +17.60%
on 04/09/25
Period Open: 15.34
29.60 -74.49%
on 10/24/24
-7.79 (-50.78%)
since 04/10/24

Most Recent Stories

More News
Investors Eye Biotech Stocks as Cancer Therapies Take Center Stage in 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As the new year begins, the American Association for Cancer Research (AACR) has highlighted expert predictions...

ONCY : 0.5001 (-3.77%)
TYRA : 7.55 (-4.67%)
ZNTL : 1.1300 (-3.42%)
ONC.TO : 0.70 (-5.41%)
CMPX : 1.6500 (-5.71%)
CCCC : 1.2100 (-6.92%)
Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

TYRA : 7.55 (-4.67%)
Tyra Biosciences to Present at Upcoming Investor Conferences

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance...

TYRA : 7.55 (-4.67%)
Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance...

TYRA : 7.55 (-4.67%)

Business Summary

Tyra Biosciences Inc. is a precision oncology company. It focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. The company's lead product candidate includes TYRA-300. Tyra Biosciences Inc. is based in CARLSBAD, Calif.

See More

Key Turning Points

3rd Resistance Point 8.39
2nd Resistance Point 8.03
1st Resistance Point 7.79
Last Price 7.55
1st Support Level 7.19
2nd Support Level 6.83
3rd Support Level 6.59

See More

52-Week High 29.60
Fibonacci 61.8% 20.75
Fibonacci 50% 18.01
Fibonacci 38.2% 15.27
Last Price 7.55
52-Week Low 6.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar